FATE AND BIOLOGICAL ACTION OF HUMAN RECOMBINANT INTERLEUKIN 1-BETA IN THE RAT INVIVO
FATE AND BIOLOGICAL ACTION OF HUMAN RECOMBINANT INTERLEUKIN 1-BETA IN THE RAT INVIVO
复制标题
DOI:
10.1002/eji.1830190821
复制
发表时间:
1989-08-01
影响因子:
5.4
通讯作者:
HEINRICH, PC
中科院分区:
文献类型:
--
作者:
KLAPPROTH, J;CASTELL, J;HEINRICH, PC
The plasma half life of recombinant human interleukin 1.beta. (rhIL 1.beta.) was determined in rats by measuring the disappearance of the radioactivity of 125I-labeled rhIL 1.beta. from the circulation. The plasma clearance showed a biphasic behavior: an initial fast disappearance (half life of about 3 min) was followed by a second slower one (half life of about 4 h). Twenty minutes after a single-dose injection of 125I-labeled rhIL 1.beta. most of the radioactivity was concentrated in kidneys, liver and intestine. rhIL 1.beta. induced the synthesis of .alpha.1-acid glycoprotein (AGP), .alpha.1-cysteine proteinase inhibitor (CPI) and .beta.-fibrinogen mRNA in liver. Half maximal stimulation was elicited by approximately 3000 U of rhIL 1.beta. per animal. The mRNA changes for AGP and CPI were followed by corresponding protein increases in serum. Twenty hours after rhIL 1.beta. injection, serum AGP rose from 0.7 to 2.5 mg/ml. CPI increased from 0.3 to 1.9 mg/ml 25 h after administration of rhIL 1.beta.. Within 20 h after rhIL 1.beta. injection, albumin serum concentration showed a strong decrease, preceded by a reduction in hepatic albumin mRNA levels. Neither changes in albumin synthesis nor degradation can explain this decrease suggesting that other mechanisms such as increased transvascular permeability are involved.